Not all sufferers with CLL have to have therapy. Inspite of all recent advances, the iwCLL however recommends watchful observation for patients with asymptomatic sickness.86 This suggestion relies on at least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). れたかを表しており，円が小さいほどその地点... https://emilyv753pwd9.blog-a-story.com/profile